Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia.
about
Olive oil and postprandial hyperlipidemia: implications for atherosclerosis and metabolic syndrome.Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss dietAtorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic menInhibition of intestinal cholesterol absorption decreases atherosclerosis but not adipose tissue inflammationThe Interpretation of Cholesterol Balance Derived Synthesis Data and Surrogate Noncholesterol Plasma Markers for Cholesterol Synthesis under Lipid Lowering TherapiesKey intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance.Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies.Lipid-lowering effects of ezetimibe and simvastatin in combination.Gut-liver interaction in triglyceride-rich lipoprotein metabolism.Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.Demystifying the management of hypertriglyceridaemia.Chylomicronaemia--current diagnosis and future therapies.Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies.The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia.Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance.Effects of ezetimibe/simvastatin 10/20 mg vs. atorvastatin 20 mg on apolipoprotein B/apolipoprotein A1 in Korean patients with type 2 diabetes mellitus: results of a randomized controlled trial.Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice.Role of the apical and basolateral domains of the enterocyte in the regulation of cholesterol transport by a high glucose concentration.Substitution of dietary ω-6 polyunsaturated fatty acids for saturated fatty acids decreases LDL apolipoprotein B-100 production rate in men with dyslipidemia associated with insulin resistance: a randomized controlled trial.Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study.Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance.
P2860
Q30240705-F5AC958C-6078-428C-994B-57953C0C28C2Q33804734-F90086A9-47B2-49A3-BE6F-0084B3E7D8C2Q34560789-A251C163-27C1-4761-86F8-67BE367B957FQ36302750-80488833-E2EA-497E-AE67-3C2BBAA80093Q36315691-BFBA963F-9F06-4A61-9E6E-606B6DFBABE5Q37590276-7FA6F386-FAF1-4CF1-AF46-7299F42144FEQ37772510-2009C547-17A9-45D8-8A26-401172B09A01Q37859778-6441AC9D-BB18-4E83-9760-D51633A7A219Q37892758-91AF0293-6A6F-4603-B7FB-6848C06DAD91Q38076370-E0CA8516-398D-4E3C-974C-2E09E1990F59Q38141575-E4E1B41D-1E35-44BE-BB32-B8B15DDCBA1BQ38366873-B4EB1800-4EC0-492F-8D3F-4235F18EBF9EQ38446859-162F25EF-C43D-4D09-989E-C4C798758ADEQ38460480-9525AEC8-5065-4300-96A0-41BF6A61771BQ38742876-BB7F3111-0E60-479C-AC62-F6A6F895B316Q42662009-4C4C655A-D11F-4C38-86D3-02E220E11B24Q44156647-470E0CC3-E8A3-4ED7-8AD2-4D90BE7EE4BBQ46055519-ABA09280-1CBD-4C11-B831-AF3479D93682Q46424797-529C6A8C-0C64-4153-A434-C44C0D876394Q49577642-B980BD10-0D0E-4CA1-B34A-5AF05D81B544Q51350715-A7AAC243-2C49-497A-99C3-6AD9A58C8B24Q51615169-3B644F6A-6DFC-4922-B6B9-990D7B083FBF
P2860
Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Effects of ezetimibe and simva ...... les with mixed hyperlipidemia.
@en
type
label
Effects of ezetimibe and simva ...... les with mixed hyperlipidemia.
@en
prefLabel
Effects of ezetimibe and simva ...... les with mixed hyperlipidemia.
@en
P2860
P1476
Effects of ezetimibe and simva ...... ales with mixed hyperlipidemia
@en
P2093
André J Tremblay
Jean-Charles Hogue
P2860
P304
P356
10.1194/JLR.P800061-JLR200
P577
2009-03-22T00:00:00Z